Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti, Vania, Meringa, Angelo, Dunnebach, Ester, van Velzen, Alice, Moreira, Aida Valera, Stam, Ronald W, Kotecha, Rishi S, Krippner-Heidenreich, Anja, Heidenreich, Olaf T, Plantinga, Maud, Cornel, Annelisa, Sebestyen, Zsolt, Kuball, Jurgen, van Til, Niek P, Nierkens, S
Published in Journal for immunotherapy of cancer (05.04.2024)
Published in Journal for immunotherapy of cancer (05.04.2024)
Get full text
Journal Article